References: |
CHIR-99021 (CT99021) is a glycogen synthase kinase 3β (GSK3β) inhibitor that has antiproliferative activity in vitro and in vivo. CHIR-99021 inhibits GSK-3 with IC50 at 7 nM. In a series of carcinoma cell lines, the IC50 of CHIR99021 For proliferation is about 10μM.
For the detailed information about the solubility of CHIR-99021 (CT99021) in water, the solubility of CHIR-99021 (CT99021) in DMSO, the solubility of CHIR-99021 (CT99021) in PBS buffer, the animal experiment(test) of CHIR-99021 (CT99021),the in vivo,in vitro and clinical trial test of CHIR-99021 (CT99021),the cell experiment(test) of CHIR-99021 (CT99021),the IC50, EC50 and Affinity of CHIR-99021 (CT99021), please contact DC Chemicals. |